ELTX - Elicio Therapeutics, Inc.
4.96
-0.170 -3.427%
Share volume: 28,170
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$5.13
-0.17
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-13-2024 | 11-13-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 10.241 M | 10.924 M | 10.344 M | |
| Selling general and admin | 2.682 M | 2.744 M | 3.136 M | |
| Research and development | 7.559 M | 8.180 M | 7.208 M | |
| Total expenses | 10.241 M | 10.924 M | 10.344 M | |
| 6.67% | -5.31% | |||
| Operating income | -10.241 M | -10.924 M | -10.344 M | |
| Ebit | -11.941 M | -7.317 M | -18.886 M | |
| Pretax income | -11.827 M | -7.229 M | -18.838 M | |
| -38.88% | 160.59% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -11.827 M | -7.229 M | -18.838 M | |
| 38.88% | -160.59% |
